Jan 5, 2016 7:00 am EST VolitionRx Announces Dr. Jason Terrell's Transition to Full-Time Status as Chief Medical Officer and Head of U.S. Operations
Dec 8, 2015 7:00 am EST VolitionRx Demonstrates More Than 90% Accuracy for Colorectal Cancer NuQ(R) Blood Test in Completed Prospective Study
Nov 19, 2015 7:00 am EST VolitionRx Demonstrates NuQ® Blood Test Detects Lung Cancers with more than 90% Accuracy
Nov 4, 2015 6:30 am EST VolitionRx Announces Third Quarter 2015 Financial Results and Business Update
Oct 30, 2015 7:00 am EDT VolitionRx Schedules Third Quarter 2015 Earnings Conference Call and Business Update for Wednesday, November 4, 2015 at 8:30am ET
